BBR Partners »

Lyell Immunopharma shares owned by BBR Partners

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by BBR Partners from 13F filings

Historical chart of BBR Partners investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by BBR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by BBR Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $210k 6.8k 30.78

More positions owned by BBR Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ab Active Etfs Intl Low Volatlt (ILOW)
Ishares Tr Core S&p500 Etf (IVV)
United Parcel Service CL B (UPS)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Kkr & Co Cl A (KKR)
Exchange Listed Fds Tr Long Pond Real E (LPRE)
Vanguard World Fds Inf Tech Etf (VGT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Philip Morris International (PM)
Alphabet Cap Stk Cl C (GOOG)

View all positions for BBR Partners

Top funds holding Lyell Immunopharma

Arch Venture Corp
MWG Management
Vanguard Group
Foresite Capital Management IV
Orland Properties
Almitas Capital
Foresite Capital Management V
Citadel Advisors
venBio Partners
Alphabet
BlackRock
Geode Capital Management
Susquehanna International
Sc China Holding
Millennium Management

View all funds holding Lyell Immunopharma